MediPharm Labs Corp. (OTCMKTS:MEDIF) Short Interest Update

MediPharm Labs Corp. (OTCMKTS:MEDIF) was the target of a significant growth in short interest in March. As of March 13th, there was short interest totaling 166,500 shares, a growth of 159.3% from the February 26th total of 64,199 shares. Based on an average trading volume of 368,096 shares, the short-interest ratio is presently 0.5 days. Based on an average trading volume of 368,096 shares, the short-interest ratio is presently 0.5 days.

MediPharm Labs Price Performance

MediPharm Labs stock traded down $0.00 during midday trading on Wednesday, hitting $0.05. The company’s stock had a trading volume of 1,650 shares, compared to its average volume of 93,566. The company has a 50-day moving average price of $0.05 and a two-hundred day moving average price of $0.05. MediPharm Labs has a 1-year low of $0.04 and a 1-year high of $0.08.

MediPharm Labs Company Profile

MediPharm Labs Corporation is a Canada-based company focused on the extraction, formulation and manufacturing of pharmaceutical-grade cannabis products. Through proprietary processes and a GMP-compliant facility in Mississauga, Ontario, the company produces high-purity distillates, isolates and advanced formulations tailored to both medical and adult-use markets.

The company’s core offerings include THC and CBD distillates, crystalline isolates, softgel capsules, oral thin films and sterile injectable products.